Claire L. Langrish
Impact in
- Immunology top 0.2%
- Psoriasis: Treatment and Pathogenesis
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immunodeficiency and Autoimmune Disorders
- IL-33, ST2, and ILC Pathways
- Dermatology top 0.5%
- Dermatology and Skin Diseases
Papers in
- Genetics 8
- Chronic Lymphocytic Leukemia Research 8
- Immunology 10
- Immunodeficiency and Autoimmune Disorders 5
- Psoriasis: Treatment and Pathogenesis 4
- T-cell and B-cell Immunology 3
- Co-authors
- Robert A. KasteleinJ. DanielYi ChenWendy M. BlumenscheinTerrill K. McClanahanJeanine MattsonBeth BashamCraig A. Murphy
- Journals
- The Journal of Experimental Medicine (3 papers)The Journal of Immunology (2 papers)Clinical and Translational Science (2 papers)Blood (1 paper)ImmunoHorizons (1 paper)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Claire L. Langrish
15 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Immunology 4.7k
- Dermatology 667
- Pathology and Forensic Medicine 1.0k
- Hematology 490
- Rheumatology 661
Countries citing papers authored by Claire L. Langrish
This map shows the geographic impact of Claire L. Langrish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire L. Langrish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire L. Langrish more than expected).
Fields of papers citing papers by Claire L. Langrish
This network shows the impact of papers produced by Claire L. Langrish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire L. Langrish. The network helps show where Claire L. Langrish may publish in the future.
Co-authors
The 25 scholars most cited alongside Claire L. Langrish, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2021 | 36 | |
| 3 | 2021 | 68 | |
| 4 | 2021 | 4 | |
| 5 | 2021 | 12 | |
| 6 | 2020 | 1 | |
| 7 | 2018 | 62 | |
| 8 | 2017 | 15 | |
| 9 | 2017 | 19 | |
| 10 | 2007 | 322 | |
| 11 | 2007 | 38 | |
| 12 | IL-23 drives a pathogenic T cell population that induces autoimmune inflammation Hit paper breakdown → | 2005 | 3244 |
| 13 | IL‐12 and IL‐23: master regulators of innate and adaptive immunity Hit paper breakdown → | 2004 | 595 |
| 14 | Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation Hit paper breakdown → | 2003 | 1327 |
| 15 | 2002 | 153 |
About Claire L. Langrish
Claire L. Langrish is a scholar working on Genetics, Immunology, Dermatology, Pathology and Forensic Medicine and Hematology, having authored 15 papers that have together received 5.9k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (8 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Psoriasis: Treatment and Pathogenesis (4 papers), Autoimmune Bullous Skin Diseases (4 papers), T-cell and B-cell Immunology (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Dermatology and Skin Diseases (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Immunology (4.7k citations), Dermatology (667 citations), Pathology and Forensic Medicine (1.0k citations), Hematology (490 citations) and Rheumatology (661 citations). Claire L. Langrish has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Robert A. Kastelein, J. Daniel, Yi Chen, Wendy M. Blumenschein, Terrill K. McClanahan, Jeanine Mattson, Beth Basham, Craig A. Murphy, Jonathon D. Sedgwick and René de Waal Malefyt. Their work appears in journals such as The Journal of Experimental Medicine, The Journal of Immunology, Clinical and Translational Science, Blood and ImmunoHorizons.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.